NATALIE ENGELKEN: Open Payments
NPI 1417400656 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 25 payments from 8 companies in 2025. Trend: 2023 $94 · 2024 $156 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $232 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Biogen, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $37 |
| Cepheid | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $7 |
Products named: UBRELVY, VRAYLAR, QULIPTA, ZURZUVAE, GeneXpert, FARXIGA, JOURNAVX, INSPIRE.
Industry payments across AR — which companies pay providers there.
